SCHEMBL5578040

SCHEMBL5578040

NC(=O)c1nc2[nH]nc(Br)c2s1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.32
DYRK1B Q9Y463 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4752790 0.81 ILK (0.32)
SCHEMBL3500615 0.76 ALDH1A1 (0.31)
SCHEMBL3501617 0.74 GRM2 (0.38) DYRK1ADYRK1B
SCHEMBL3501102 0.72 CYP1A2 (0.43)
SCHEMBL14454810 0.67 KMT2A (0.49)
SCHEMBL5577976 0.67 CYP1A2 (0.36) DYRK1A
SCHEMBL18549579 0.62 SMN1; SMN2 (0.35)
SCHEMBL18555195 0.62 AURKA (0.40) DYRK1ADYRK1B
SCHEMBL16751925 0.61 ALDH1A1 (0.34) DYRK1ADYRK1B
SCHEMBL473007 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators MAP4K2, MAP4K5, MAP4K3 DYRK1A 577/4885DYRK1B 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.